FIELD: medicine.
SUBSTANCE: group of inventions relates to agent containing or consisting of (a) antibody or its antigen-binding fragment with specificity to human glandular kallikrein (hK2) and (b) cytotoxic molecules for treating prostate cancer, method of treating prostate cancer, which involves stage of administering therapeutically effective amount of agent containing or consisting of (a) antibody or its antigen-binding fragment with specificity to human glandular kallikrein (hK2) and (b) cytotoxic molecules, as well as composition and kit for treating prostate cancer.
EFFECT: group of inventions is aimed at mitigation, reducing or eliminating deficiencies in treating prostate cancer.
78 cl, 50 dwg, 4 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBODIES POLYPEPTIDES AND USE THEREOF | 2014 |
|
RU2687163C1 |
| ANTIBODY POLYPEPTIDES AND THEIR APPLICATION | 2016 |
|
RU2753677C2 |
| NOVEL RADIOIMMUNOCONJUGATES AND THEIR APPLICATIONS | 2011 |
|
RU2560587C9 |
| NOVEL RADIOIMMUNOCONJUGATES AND USE THEREOF | 2011 |
|
RU2664475C1 |
| METHOD AND PREPARATION FOR TREATING THE CASES OF FLAT CELL CANCER | 1996 |
|
RU2193779C2 |
| RADIOACTIVE METAL-LABELLED ANTI-CADHERIN ANTIBODY | 2011 |
|
RU2577125C2 |
| PARAMINOHYPURIC ACID (PAH) AS A KIDNEY PROTECTOR | 2020 |
|
RU2804349C2 |
| ANTI HUMAN INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN (IL1RAP) ANTIBODIES AND USES THEREOF | 2015 |
|
RU2710787C2 |
| USE OF CD 151 ANTIBODIES FOR TREATING CANCER | 2007 |
|
RU2464041C2 |
| TREATMENT OF B-CELLULAR MALIGNANT TUMORS USING ANTI-CD40L ANTIBODIES IN COMBINATION WITH ANTI-CD20 ANTIBODIES AND/OR BY CHEMOTHERAPY AND RADIOTHERAPY | 2000 |
|
RU2305561C2 |
